Group leader Camila Esguerra from Centre for Molecular Medicine at Unversity of Oslo, Norway, provides two examples of how to use Zebrafish models to study drug candidate toxicity, mechanism of action. disease mechanism and drug screening in various diseases
Using Zebrafish to Model Neurodevelopmental Disorders and Cancer
The Innovation Management Toolbox was originally developed through funding from the EJP RD project, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825575.
The continued development and maintenance of the Toolbox are now supported by the ERDERA partnership, funded under the European Union’s Horizon Europe Research & Innovation programme, grant agreement No. 101156595.